TRML
Tourmaline Bio
TRML
TRML
Delisted
TRML was delisted on the 27th of October, 2025.
92 hedge funds and large institutions have $541M invested in Tourmaline Bio in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 26 increasing their positions, 27 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
10% more funds holding
Funds holding: 84 → 92 (+8)
0.44% less ownership
Funds ownership: 82.47% → 82.03% (-0.44%)
4% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 27
Holders
92
Holding in Top 10
5
Calls
$262K
Puts
$236K
Top Buyers
| 1 | +$13.1M | |
| 2 | +$8.7M | |
| 3 | +$6.35M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$3.7M |
| 5 |
State Street
Boston,
Massachusetts
|
+$2.16M |
Top Sellers
| 1 | -$5.7M | |
| 2 | -$4.76M | |
| 3 | -$3.1M | |
| 4 |
Two Sigma Investments
New York
|
-$3.08M |
| 5 |
Morgan Stanley
New York
|
-$2.32M |